Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

120.98
Delayed Data
As of Apr 21
 -0.23 / -0.19%
Today’s Change
97.52
Today|||52-Week Range
169.89
-15.65%
Year-to-Date

Today’s Trading

Previous close121.21
Today’s open121.33
Day’s range120.06 - 121.90
Volume828,522
Average volume (3 months)621,902
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-11.96%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio7.9
Price/Sales4.20
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...+1.35+3.15%
GRFSGrifols SA+0.13+0.66%
TAROTaro Pharmaceutical ...-1.04-0.89%
MNKMallinckrodt Plc-1.41-3.14%
Data as of 4:02pm ET, 04/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$3.24
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts


Search for Jobs